The problem of trachoma within an onchocerciasis-endemic zone in Kaduna: Need for a multilateral approach?

Ophthalmic Epidemiology

Volumn 12, Issue 5, 2005, Pages 311-319

  Babalola, O E ^a   Abiose, A ^b   Barrie, J R ^c  

^a Rachel Eye Center   (Nigeria)

^b National Eye Centre   (Nigeria)

^c International Centre for Eye Health   (United Kingdom)

Author keywords

Blindness; Entropion; Nigeria; Ocular morbidity; Onchocerciasis; SAFE strategy; Trachoma epidemiology; Trachoma prevention; Underdeveloped countries

Indexed keywords

IVERMECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CATARACT; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NIGERIA; ONCHOCERCIASIS; PREVALENCE; PRIORITY JOURNAL; SCAR FORMATION; TRACHOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPARASITIC AGENTS; BLINDNESS; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; ENDEMIC DISEASES; FEMALE; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; NIGERIA; ONCHOCERCIASIS, OCULAR; PREVALENCE; RURAL POPULATION; TRACHOMA;

EID: 28244496116     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580591005787     Document Type: Article

References (16)

1. West SK. Trachoma: New assault on an ancient disease. Progr Retinal Eye Res. 2004;23(4):381-401.
2. Kumaresan JA, Mecaskey JW. The global elimination of blinding trachoma: progress and promise. Am J Trop Med Hyg. 2003;69(5 supp):24-28.
3. Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull WHO. 1999;77(6):461-466.
4. Babalola OE, Bage SDT. The persistence of chlamydial inclusions in clinically quiescent trachoma. West Afr J Med. 1992;11(1):55-61.
5. Burton MJ, Holland MJ, Faal N, et al. Which members of a community need antibiotics to control trachoma? Invest Ophthalmol Vis Sci. 2003;44(10):4215- 4222.
6. Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: Observational study with quantitative PCR. Lancet. 2003;362(9739):181-182.
7. Abiose A, Jones BR, Cousens S, et al. Reduction in incidence of optic nerve disease with annual ivermectin for onchocerciasis. Lancet. 1993;341:130-134.
8. Abiose A, Murdoch I, Babalola O, et al. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Br J Ophthalmol. 1994;78(1): 8-13.
9. Murdoch I, Jones BR, Babalola OE, et al. Red dot card test of the paracentral field as a screening test for optic nerve disease in onchocerciasis. Bull WHO. 1996;74(6):573-576.
10. Landers A, Murdoch IE, Birch I, et al. Blue yellow color vision in onchocercal area of Northern Nigeria. Br J Ophthalmol. 1998;82(5): 510-516.
11. Bailey R, Lietman T. The SAFE strategy for the elimination of trachoma by 2020: will it work? Bull WHO. 2001;79(3):233-236.
12. Babalola OE, Murdoch I, Abiose AA. Mobile eye surgery in rural communities of Northern Nigeria: An experience. Nigerian J Ophthalmol. 1993;2(1):16-20.
13. Babalola OE. Correction of trachomatous entropion/trichiasis in Kaduna. An assessment of 2 simplified methods. East Afr Med J. 1988;65:525-531.
14. Wooldridge M (ed). Specialist eye health guidelines. Office of Aboriginal and Torres Strait Islander Health, Australian Commonwealth Department of Health and Aged Care, 2001.
15. West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol. 1991;20(4):1088-1092.
16. Babalola OE. Trachoma in Kaduna, Northern Nigeria: Recent observations on pattern of clinical presentation. Trop Geogr Med. 1988;41:41-44.